Cargando…
Report from the International Viral Hepatitis Elimination Meeting (IVHEM), 17–18 November 2017, Amsterdam, the Netherlands: gaps and challenges in the WHO 2030 hepatitis C elimination framework
The current global burden of hepatitis C (HCV) is estimated at 71 million people. The World Health Organization (WHO) has stated that HCV could be eliminated as a public health threat by 2030. A key recommendation to reach this elimination goal is to reduce new infections by 90% and liver-related mo...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Mediscript Ltd
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6038125/ https://www.ncbi.nlm.nih.gov/pubmed/30050685 |
_version_ | 1783338433139179520 |
---|---|
author | Popping, Stephanie El-Sayed, Manal Feld, Jordan Hatzakis, Angelos Hellard, Margaret Lesi, Olufunmilayo Ninburg, Michael Ward, John Boucher, Charles |
author_facet | Popping, Stephanie El-Sayed, Manal Feld, Jordan Hatzakis, Angelos Hellard, Margaret Lesi, Olufunmilayo Ninburg, Michael Ward, John Boucher, Charles |
author_sort | Popping, Stephanie |
collection | PubMed |
description | The current global burden of hepatitis C (HCV) is estimated at 71 million people. The World Health Organization (WHO) has stated that HCV could be eliminated as a public health threat by 2030. A key recommendation to reach this elimination goal is to reduce new infections by 90% and liver-related mortality by 65%. Countries are encouraged by the WHO to develop their own national elimination programmes in order to reach these goals. However, various gaps and challenges, such as the lack of high-quality epidemiological data, stigmatisation, and optimisation of the cascade of care, have arisen in the WHO strategic framework. The International Viral Hepatitis Elimination Meeting (IVHEM) has therefore established an expert panel made of clinicians, virologists, and public health specialists to discuss and address these challenges. This review highlights the outcome and proposed solutions to attempt at facilitating HCV elimination. |
format | Online Article Text |
id | pubmed-6038125 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | Mediscript Ltd |
record_format | MEDLINE/PubMed |
spelling | pubmed-60381252018-07-26 Report from the International Viral Hepatitis Elimination Meeting (IVHEM), 17–18 November 2017, Amsterdam, the Netherlands: gaps and challenges in the WHO 2030 hepatitis C elimination framework Popping, Stephanie El-Sayed, Manal Feld, Jordan Hatzakis, Angelos Hellard, Margaret Lesi, Olufunmilayo Ninburg, Michael Ward, John Boucher, Charles J Virus Erad Conference Report The current global burden of hepatitis C (HCV) is estimated at 71 million people. The World Health Organization (WHO) has stated that HCV could be eliminated as a public health threat by 2030. A key recommendation to reach this elimination goal is to reduce new infections by 90% and liver-related mortality by 65%. Countries are encouraged by the WHO to develop their own national elimination programmes in order to reach these goals. However, various gaps and challenges, such as the lack of high-quality epidemiological data, stigmatisation, and optimisation of the cascade of care, have arisen in the WHO strategic framework. The International Viral Hepatitis Elimination Meeting (IVHEM) has therefore established an expert panel made of clinicians, virologists, and public health specialists to discuss and address these challenges. This review highlights the outcome and proposed solutions to attempt at facilitating HCV elimination. Mediscript Ltd 2018-07-01 /pmc/articles/PMC6038125/ /pubmed/30050685 Text en © 2018 The Authors. Journal of Virus Eradication published by Mediscript Ltd http://creativecommons.org/licenses/by-nc/4.0/ This is an open access article published under the terms of a Creative Commons License. |
spellingShingle | Conference Report Popping, Stephanie El-Sayed, Manal Feld, Jordan Hatzakis, Angelos Hellard, Margaret Lesi, Olufunmilayo Ninburg, Michael Ward, John Boucher, Charles Report from the International Viral Hepatitis Elimination Meeting (IVHEM), 17–18 November 2017, Amsterdam, the Netherlands: gaps and challenges in the WHO 2030 hepatitis C elimination framework |
title | Report from the International Viral Hepatitis Elimination Meeting (IVHEM), 17–18 November 2017, Amsterdam, the Netherlands: gaps and challenges in the WHO 2030 hepatitis C elimination framework |
title_full | Report from the International Viral Hepatitis Elimination Meeting (IVHEM), 17–18 November 2017, Amsterdam, the Netherlands: gaps and challenges in the WHO 2030 hepatitis C elimination framework |
title_fullStr | Report from the International Viral Hepatitis Elimination Meeting (IVHEM), 17–18 November 2017, Amsterdam, the Netherlands: gaps and challenges in the WHO 2030 hepatitis C elimination framework |
title_full_unstemmed | Report from the International Viral Hepatitis Elimination Meeting (IVHEM), 17–18 November 2017, Amsterdam, the Netherlands: gaps and challenges in the WHO 2030 hepatitis C elimination framework |
title_short | Report from the International Viral Hepatitis Elimination Meeting (IVHEM), 17–18 November 2017, Amsterdam, the Netherlands: gaps and challenges in the WHO 2030 hepatitis C elimination framework |
title_sort | report from the international viral hepatitis elimination meeting (ivhem), 17–18 november 2017, amsterdam, the netherlands: gaps and challenges in the who 2030 hepatitis c elimination framework |
topic | Conference Report |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6038125/ https://www.ncbi.nlm.nih.gov/pubmed/30050685 |
work_keys_str_mv | AT poppingstephanie reportfromtheinternationalviralhepatitiseliminationmeetingivhem1718november2017amsterdamthenetherlandsgapsandchallengesinthewho2030hepatitisceliminationframework AT elsayedmanal reportfromtheinternationalviralhepatitiseliminationmeetingivhem1718november2017amsterdamthenetherlandsgapsandchallengesinthewho2030hepatitisceliminationframework AT feldjordan reportfromtheinternationalviralhepatitiseliminationmeetingivhem1718november2017amsterdamthenetherlandsgapsandchallengesinthewho2030hepatitisceliminationframework AT hatzakisangelos reportfromtheinternationalviralhepatitiseliminationmeetingivhem1718november2017amsterdamthenetherlandsgapsandchallengesinthewho2030hepatitisceliminationframework AT hellardmargaret reportfromtheinternationalviralhepatitiseliminationmeetingivhem1718november2017amsterdamthenetherlandsgapsandchallengesinthewho2030hepatitisceliminationframework AT lesiolufunmilayo reportfromtheinternationalviralhepatitiseliminationmeetingivhem1718november2017amsterdamthenetherlandsgapsandchallengesinthewho2030hepatitisceliminationframework AT ninburgmichael reportfromtheinternationalviralhepatitiseliminationmeetingivhem1718november2017amsterdamthenetherlandsgapsandchallengesinthewho2030hepatitisceliminationframework AT wardjohn reportfromtheinternationalviralhepatitiseliminationmeetingivhem1718november2017amsterdamthenetherlandsgapsandchallengesinthewho2030hepatitisceliminationframework AT bouchercharles reportfromtheinternationalviralhepatitiseliminationmeetingivhem1718november2017amsterdamthenetherlandsgapsandchallengesinthewho2030hepatitisceliminationframework |